Contact
searchSearch
HMP Global

Clinical Pearls

David Rosmarin
Clinical Pearls
Comorbidities Associated With Vitiligo
05/05/2025
David Rosmarin, MD
Explore key clinical insights on vitiligo comorbidities, including thyroid dysfunction and emerging links to subclinical hearing loss.
Explore key clinical insights on vitiligo comorbidities, including thyroid dysfunction and emerging links to subclinical hearing loss.
Explore key clinical insights on...
05/05/2025
APP Institute Dermatology
Lauren McGrath
Clinical Pearls
Systemic Treatments for Type 2 Inflammation
04/15/2025
Lauren McGrath
Explore new systemic treatments for type 2 inflammation in atopic dermatitis, including lebrikizumab, nemolizumab, upadacitinib, and dupilumab.
Explore new systemic treatments for type 2 inflammation in atopic dermatitis, including lebrikizumab, nemolizumab, upadacitinib, and dupilumab.
Explore new systemic treatments...
04/15/2025
APP Institute Dermatology
Joy Wan
Clinical Pearls
Proactive Therapy for AD
04/05/2025
Joy Wan, MD, MSCE, FAAD
Proactive therapy for atopic dermatitis focuses on maintaining remission by addressing subclinical inflammation, even after visible symptoms subside.
Proactive therapy for atopic dermatitis focuses on maintaining remission by addressing subclinical inflammation, even after visible symptoms subside.
Proactive therapy for atopic...
04/05/2025
APP Institute Dermatology
Lauren McGrath
Clinical Pearls
Topical Treatments for Type 2 Inflammation
03/15/2025
Lauren McGrath
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research...
03/15/2025
APP Institute Dermatology
Jeffrey M. Cohen, MD
Clinical Pearls
Congestive Heart Failure and Psoriasis
03/10/2025
Jeffrey M. Cohen, MD
Dr Cohen explores the epidemiologic link between psoriasis and congestive heart failure (CHF), emphasizing the potential risks of TNF-alpha inhibitors in these patients.
Dr Cohen explores the epidemiologic link between psoriasis and congestive heart failure (CHF), emphasizing the potential risks of TNF-alpha inhibitors in these patients.
Dr Cohen explores the...
03/10/2025
APP Institute Dermatology
Peter Lio
Clinical Pearls
Why Alternative Medicine?
02/18/2025
Peter Lio, MD, FAAD
While some clinicians dismiss alternative medicine, patient interest underscores its relevance.
While some clinicians dismiss alternative medicine, patient interest underscores its relevance.
While some clinicians dismiss...
02/18/2025
APP Institute Dermatology
Peter Lio
Clinical Pearls
Environmental Impact on Atopy
02/12/2025
Peter Lio, MD, FAAD
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link...
02/12/2025
APP Institute Dermatology
Matthew Zirwas, MD
Clinical Pearls
How to Ask About Itch
02/04/2025
Matthew J. Zirwas, MD
Traditional itch scales like the Peak Pruritus Numerical Rating Scale offer limited clinical value as single-day snapshots. Instead, dermatologists advocate for functional assessments, focusing on how itch impacts daily activities and sleep.
Traditional itch scales like the Peak Pruritus Numerical Rating Scale offer limited clinical value as single-day snapshots. Instead, dermatologists advocate for functional assessments, focusing on how itch impacts daily activities and sleep.
Traditional itch scales like the...
02/04/2025
APP Institute Dermatology
Joy Wan
Clinical Pearls
Systemic Therapies for AD
01/10/2025
Joy Wan, MD, MSCE, FAAD
An overview of systemic treatments for atopic dermatitis, from traditional options to modern biologics and JAK inhibitors, focusing on benefits, risks, and personalized care.
An overview of systemic treatments for atopic dermatitis, from traditional options to modern biologics and JAK inhibitors, focusing on benefits, risks, and personalized care.
An overview of systemic...
01/10/2025
APP Institute Dermatology
Gil Yosipovitch, MD,
Clinical Pearls
Dupilumab for Adults With Prurigo Nodularis: A Critical Review
11/14/2024
Gil Yosipovitch, MD
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
APP Institute Dermatology
APP Institute Dermatology

 

The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of patient care across the spectrum of dermatology.

The APP Institute | Dermatology is designed for Advanced Practice Providers who specialize in Dermatology, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with Dermatology. Engage year-round with the Dermatology Learning Network to access clinical insights, interactive features, research news updates, accredited continuing education programs, and more.

August 16-17 | Complimentary Virtual Event | Register Now

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use